SLU-PP-332 Explained: Exercise Mimetic or Experimental Hype?
Summary
Host John Garrett examines SLU-PP332, an experimental small molecule marketed as an "exercise mimetic" that activates estrogen-related receptors to boost mitochondrial function. While mouse studies show improved endurance and fat oxidation, the episode clarifies that SLU-PP332 is not a peptide and lacks human safety or efficacy data. Garrett warns against using this unapproved research chemical due to poor oral bioavailability and unknown long-term risks, emphasizing it cannot replace the comprehensive benefits of actual physical training.
Topics discussed
Introduction to SLU-PP332 and the 'exercise mimetic' concept
Clarifying SLU-PP332 as a small molecule, not a peptide
Mechanism: Activating Estrogen-Related Receptors (ERRs)
How ERR activation mimics metabolic signals of exercise
Preclinical findings: Mouse studies on endurance and fat loss
The lack of human clinical evidence and safety data
Oral bioavailability issues and next-generation compounds
Separating plausible claims from unproven human benefits
Theoretical risks, unknowns, and cancer biology concerns
Regulatory status and quality control in research markets
60-second summary of mechanism and evidence gaps
Evaluation questions and call for real-world reports
Conclusion: Promising mechanism vs. proven medicine
Listen ad-free on Castria